Pulmonary function testing

Respiratory Care

Volumn 57, Issue 1, 2012, Pages 165-175

  Ruppel, Gregg L ^a   Enright, Paul L ^a  

^a SAINT LOUIS UNIVERSITY HOSPITAL   (United States)

Author keywords

Pulmonary function testing

Indexed keywords

AIRWAY RESISTANCE; ARTICLE; ASTHMA; CHILD HEALTH CARE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL COMPETENCE; CLINICAL DECISION MAKING; DISEASE CLASSIFICATION; EXERCISE TEST; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; INHALATION TEST; INTERMETHOD COMPARISON; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; LUNG VOLUME; NORMAL VALUE; PATIENT IDENTIFICATION; PATIENT SELECTION; PHENOTYPE; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; REFERENCE VALUE; SPIROMETRY;

AIRWAY RESISTANCE; EXERCISE TEST; HUMANS; LABORATORIES; LUNG DISEASES; LUNG VOLUME MEASUREMENTS; PHENOTYPE; PULMONARY DIFFUSING CAPACITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SPIROMETRY;

EID: 84856779382     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.01640     Document Type: Article

References (44)

1. Global Initiative for Chronic Lung Disease. GOLD spirometry guide-2010 update. http://www.goldcopd.org/other-resources-goldspirometry-guide.html. Accessed November 2, 2011.
2. Global Initiative for Asthma. Pocket guide for asthma management and prevention. http://www.ginasthma.org/guidelines-pocket-guidefor-asthma-management.html. Accessed November 2, 2011.
3. Albouaini K, Egred M, Alahmar A, Wright DJ. Cardiopulmonary exercise testing and its application. Heart 2007;93(10):1285-1292.
4. Evans SE, Scanlon PD. Current practice in pulmonary function testing. Mayo Clin Proc 2003;78(6):758-763.
5. Miller MR, Quanjer PH, Swanney MP, Ruppel G, Enright PL. Interpreting lung function data using 80% predicted and fixed thresholds misclassifies more than 20% of patients. Chest 2011;139(1):52-59.
6. Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al; ATS/ERS Task Force. General considerations for lung function testing. Eur Respir J 2005;26(1):153-161.
7. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, et al; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J 2005;26(2):319-338.
8. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005;26(3):511-522.
9. MacIntyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005;26(4):720-735.
10. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26(5):948-968.
11. LCO testing. Respir Care 2012;57(1):17-23; discussion 23-25.
12. Ruppel GL. What is the clinical value of lung volumes? Respir Care 2012;57(1):26-35; discussion 35-38.
13. Hyatt RE, Cowl CT, Bjoraker JA, Scanlon PD. Conditions associated with an abnormal nonspecific pattern of pulmonary function tests. Chest 2009;135(2):419-424.
14. Macklem PT. Therapeutic implications of the pathophysiology of COPD. Eur Respir J 2010;35(3):676-80.
15. O'Donnell CR, Bankier AA, Stielbellehner L, Reilly JJ, Brown R, Loring SH. Comparison of plethysmographic and helium dilution lung volumes: which is best in COPD? Chest 2010;137(5):1108-1115.
16. Milite F, Lederer DJ, Weingarten JA, Fani P, Mooney AM, Basner RC. Quantification of single-breath underestimation of lung volumes in emphysema. Respir Physiol Neurobiol 2009;165(2-3):215-220.
17. Seed L, Wilson D, Coates AL. Children should not be treated like little adults in the PFT lab. Respir Care 2012;57(1):61-71; discussion71-74.
18. Kaminsky DA. What does airway resistance tell us about lung function? Respir Care 2012;57(1):85-96; discussion 96-99.
19. Pichurko BM. Exercising your patient: which test(s) and when? Respir Care 2012;57(1):100-110; discussion 110-113.
20. Crapo RO, Casaburi R, Coates AL, Enright PL; Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the 6 minute walk test. Am J Respir Crit Care Med 2002;166(1):111-117.
21. Haynes JM: Quality assurance of the pulmonary function technologist. Resp Care 2012;57(1):114-122; discussion 122-126.
22. National Board for Respiratory Care. NBRC examinations. http://www.nbrc.org/Examinations/tabid/70/Default.aspx. Accessed November 2, 2011.
23. Enright PL, Johnson LR, Connett JE, Voelker H, Buist AS. Spirometry in the Lung Health Study: 1. Methods and quality control. Am Rev Respir Dis 1991;143(6):1215-1223.
24. Walters JA. A mixed methods study to compare models of spirometry delivery in primary care for patients at risk of COPD. Thorax 2008;6(5)3:408-414.
25. Enright PL. Should we keep pushing for a spirometer in every doctor's office? Respir Care 2012;57(1):146-151; discussion 151-153.
26. Miller A, Enright PL. PFT interpretive strategies: American Thoracic Society/European Respiratory Society 2005 guideline gaps. Respir Care 2012;57(1):127-133; discussion 133-135.
27. Hankinson JL, Kawut SM, Shahar E, Smith LJ, Stukovsky KH, Barr RG. Performance of American Thoracic Society-recommended spirometry reference values in a multiethnic sample of adults: the Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study. Chest 2010;137(1):138-145.
28. Lung function in growth and aging: a united worldwide approach. http://www.lungfunction.org. Accessed November 2, 2011.
29. Miller A, Thornton JC, Warshaw R, Anderson H, Teirstein AS, Selikoff IJ. Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state; predicted values, lower limits of normal, and frequencies of abnormality by smoking history. Am Rev Respir Dis 1983;127(3):270-277.
30. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991;144(5):1202-1218.
31. Culver BH. How should the lower limit of the normal range be defined? Respir Care 2012;57(1):136-143; discussion 143-145.
32. Busse WW. What is the best pulmonary diagnostic approach for wheezing patients with normal spirometry? Respir Care 2012;57(1):39-46; discussion 47-49.
33. Cockcroft DW. Direct challenge tests. Airway hyperresponsiveness in asthma, its measurement and clinical significance. Chest 2010;138(2 Suppl):18S-24S.
34. Anderson SD. Indirect challenge tests. Airway hyperresponsiveness in asthma, its measurement and clinical significance. Chest 2010;138(2 Suppl):25S-30S.
35. Dweik RA, Boggs PB, Erzurum SC, Irvin CG, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011;184(3):602-615.
36. Salzman SH. Which pulmonary function tests best differentiate between COPD phenotypes? Respir Care 2012;57(1):50-57; discussion58-60.
37. Colice GL, Shafazand S, Griffin JP, Keenan R, Bolliger CT. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery; ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132(3 Suppl):161S-177S.
38. Hnatiuk OW. What is the role of PFTs in monitoring adverse effects of surgery, drug treatments, radiation therapy, and during hospitalization? Respir Care 2012;57(1):75-82; discussion 82-84.
39. National Heart, Lung and Blood Institute. Guidelines for the diagnosis and management of asthma (EPR-3). http://www.nhlbi.nih. gov/guidelines/asthma. Accessed November 2, 2011.
40. Dales RE, Vandemheen KL, Clinch J, Aaron SD. Spirometry in the primary care setting: influence on clinical diagnosis and management of airflow obstruction. Chest 2005;128(4):2443-2447.
41. Yawn BP, Enright PL, Lemanske RF Jr, Israel E, Pace W, Wollan P, Boushey H. Spirometry can be done in family physicians' offices and alters clinical decisions in management of asthma and COPD. Chest 2007;132(4):1162-1168.
42. MacIntyre NR. The future of pulmonary function testing. Respir Care 2012;57(1):154-161; discussion 161-164.
43. US Census Bureau. An older and more diverse nation by midcentury. http://www.census.gov/newsroom/releases/archives/population/ cb08-123.html. Accessed November 3, 2011.
44. van der Lee I, Zanen P, Grutters JC, Snijder RJ, van den Bosch JM. Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension. Chest 2006;129(3):378-383.